KIDS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OrthoPediatrics Corp (KIDS) does not present a strong buy opportunity at the moment for a beginner investor with a long-term horizon. While there are some positive indicators such as hedge fund buying and bullish technicals, the lack of significant news catalysts, mixed analyst ratings, and absence of recent AI or SwingMax trading signals suggest a cautious approach. Additionally, the stock's recent price target adjustments and lack of financial data further support holding off on immediate investment.
The technical indicators show a bullish trend. The MACD histogram is positive and expanding, the RSI is neutral at 67.548, and the moving averages (SMA_5 > SMA_20 > SMA_200) are bullish. The stock is trading above its pivot level (18.272) and is near its resistance level (R1: 18.75).
Hedge funds are actively buying the stock with a 114.29% increase in buying activity over the last quarter. The company is at the beginning of an NPL supercycle, as noted by analysts.
Analyst price targets have been mixed, with Truist lowering its target to $17, citing group multiple compression. There is no recent news or significant insider trading activity to act as a catalyst. Additionally, no recent AI Stock Picker or SwingMax signals were detected.
No financial data available for analysis. The latest quarter's financial performance could not be assessed.
Mixed ratings from analysts. Truist has a Hold rating with a price target of $17, while Canaccord has a Buy rating with a price target of $25, citing optimism around the company's execution and potential for free cash flow breakeven in FY26.
